Atavistik Bio Revenue and Competitors

Location

#8358

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Atavistik Bio's estimated annual revenue is currently $3.2M per year.(i)
  • Atavistik Bio's estimated revenue per employee is $77,500
  • Atavistik Bio's total funding is $100M.

Employee Data

  • Atavistik Bio has 41 Employees.(i)
  • Atavistik Bio grew their employee count by 3% last year.

Atavistik Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
VP, Business DevelopmentReveal Email/Phone
4
VP, Head BiologyReveal Email/Phone
5
Director, Medicinal ChemistryReveal Email/Phone
6
President and Chief Scientific OfficerReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Senior Office Manager and HR Operations SpecialistReveal Email/Phone
9
Senior Manager, Lab OperationsReveal Email/Phone
10
N/AReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Atavistik Bio?

Atavistik Bio is a new, privately-held biopharmaceutical company focused on the discovery and development of novel therapies for metabolic diseases and cancer. Our high-throughput platform for the unbiased identification of metabolite-protein interactions will enable the discovery of first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design capabilities and cutting-edge insights into the regulation of metabolic systems to apply to genetically validated targets.

keywords:N/A

$100M

Total Funding

41

Number of Employees

$3.2M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M413%N/A
#2
$4.8M41-9%N/A
#3
$9.5M410%N/A
#4
$4.3M41-2%N/A
#5
$8.2M418%N/A